Emerging Nanomedicines for the Treatment of Atopic Dermatitis.
Ontology highlight
ABSTRACT: Globally, the prevalence of Atopic dermatitis (AD) is significantly increasing and affecting around 20% of population including children. Complex interactions amongst abnormality in epidermal barrier function, environment, infectious agents and immunological defects are considered as key factors in the pathogenesis of AD. Although the role of oxidative stress has been studied in some skin diseases, investigation of the same in AD is intermittent. Calcineurin inhibitors and/or topical corticosteroids are currently available; however, it causes atrophy of the skin, burning sensation, and systemic side effects which leads to poor patient compliance. These limitations provoke the strong need to develop an innovative approach in managing AD. Nanomaterials for effective drug delivery to skin con
SUBMITTER: Parekh K
PROVIDER: S-EPMC7828097 | biostudies-literature | 2021 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA